Upgrade to SI Premium - Free Trial

Zoetis (ZTS)

79.62 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)
- M&A (Rumor)
- Activism
- M&A (N/A)
- M&A (12/31/18 *Est)

Latest Headlines

FDA approves Zoetis single-injection antibiotic for dogs October 20, 2026 4:42 PM - StreetInsider Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment October 20, 2026 4:42 PM - BizWire Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX October 20, 2026 8:43 AM - StreetInsider Jefferies Downgrades Zoetis Inc. (ZTS) to Hold October 20, 2026 5:08 AM - StreetInsider Goldman Sachs Starts Zoetis Inc. (ZTS) at Neutral October 16, 2026 4:20 AM - StreetInsider Form 4 Zoetis Inc. For: Oct 09 Filed by: PECK KRISTIN C October 13, 2026 9:14 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Esch Kevin October 13, 2026 9:14 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: FULLER JULIE October 13, 2026 9:14 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Driscoll Rimma October 13, 2026 9:14 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Sarbaugh Keith October 13, 2026 9:14 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Nayak Abhay U October 13, 2026 9:13 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Ferran Astorga Jeannette October 13, 2026 9:13 PM - SEC Filing Form 4 Zoetis Inc. For: Oct 09 Filed by: Lagano Roxanne October 13, 2026 9:13 PM - SEC Filing Form 8-K Zoetis Inc. For: Oct 08 October 13, 2026 7:33 AM - SEC Filing Zoetis appoints Iris Knobloch to its board of directors October 13, 2026 7:30 AM - StreetInsider Zoetis Appoints Iris Knobloch to its Board of Directors October 13, 2026 7:30 AM - BizWire Zoetis (ZTS) Declares $0.53 Quarterly Dividend; 2.9% Yield October 8, 2026 4:21 PM - StreetInsider Form 8-K Zoetis Inc. For: Oct 08 October 8, 2026 4:17 PM - SEC Filing Zoetis Declares Fourth Quarter 2026 Dividend October 8, 2026 4:15 PM - BizWire New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹ October 6, 2026 7:30 AM - BizWire Piper sees veterinary medicine challenges continuing through 2027 October 6, 2026 6:38 AM - StreetInsider Form 4 Zoetis Inc. For: Sep 30 Filed by: FULLER JULIE October 2, 2026 4:43 PM - SEC Filing KeyBanc Reiterates Overweight Rating on Elanco Animal Health (ELAN) September 30, 2026 8:47 AM - StreetInsider Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results September 24, 2026 7:30 AM - BizWire Form 4 Zoetis Inc. For: Sep 17 Filed by: Stetter Mark September 18, 2026 5:57 PM - SEC Filing Zoetis (ZTS) Reiterated at Hold by Stifel - AD mAb Share Losses Ahead September 18, 2026 7:57 AM - StreetInsider Form 4 Zoetis Inc. For: Aug 31 Filed by: SACCARO JAMES September 2, 2026 4:35 PM - SEC Filing Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference September 2, 2026 7:30 AM - BizWire Zoetis Inc. (ZTS) PT Lowered to $94 at TD Cowen August 25, 2026 7:40 AM - StreetInsider Form 3 Zoetis Inc. For: Aug 17 Filed by: SACCARO JAMES August 24, 2026 4:33 PM - SEC Filing Zoetis Inc. (ZTS) PT Lowered to $80 at Stifel as Key Franchise Price Realization Decelerates August 20, 2026 7:25 AM - StreetInsider Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies August 13, 2026 3:51 PM - BizWire FDA grants emergency use for Simparica TRIO to treat screwworm in dogs August 13, 2026 1:35 PM - StreetInsider FDA: issues Emergency Use Authorization for Simparica Trio to treat new world screwworm in dogs & puppies August 13, 2026 1:30 PM - StreetInsider Form 4 Zoetis Inc. For: Aug 07 Filed by: DAMELIO FRANK A August 11, 2026 4:53 PM - SEC Filing Zoetis Inc. (ZTS) PT Lowered to $80 at UBS August 7, 2026 10:14 AM - StreetInsider Zoetis Inc. (ZTS) PT Lowered to $115 at JPMorgan August 7, 2026 9:41 AM - StreetInsider Form 8-K Zoetis Inc. For: Aug 06 August 6, 2026 4:24 PM - SEC Filing Form 10-Q Zoetis Inc. For: Jun 30 August 6, 2026 2:33 PM - SEC Filing William Blair Downgrades Zoetis Inc. (ZTS) to Market Perform, 'Changing Commercial Strategies Create Too Much Uncertainty on the P&L' August 6, 2026 11:58 AM - StreetInsider Form 8-K Zoetis Inc. For: Aug 06 August 6, 2026 7:06 AM - SEC Filing Zoetis (ZTS) Tops Q2 EPS by 1c, Misses on Revenue; Offers FY26 EPS Guidance August 6, 2026 7:04 AM - StreetInsider Zoetis Announces Second Quarter 2026 Results August 6, 2026 7:01 AM - BizWire Zoetis names Jay Saccaro as CFO and COO effective August 2026 August 6, 2026 7:00 AM - StreetInsider Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer August 6, 2026 7:00 AM - BizWire Form SCHEDULE 13G/A Zoetis Inc. Filed by: BlackRock, Inc. July 30, 2026 11:20 AM - SEC Filing BofA keeps Elan as top pick in animal health sector ahead of 2Q26 July 28, 2026 5:58 AM - StreetInsider Zoetis Inc. (ZTS) PT Lowered to $85 at UBS July 27, 2026 8:55 AM - StreetInsider Full Article List